 Loss of p14ARF by a homozygous mutation in the CDKN2A (INK4A) gene will lead to elevated levels in mdm2 and, therefore, loss of p53 function and cell cycle control.The equivalent in mice is p19ARF.The p14ARF transcript was first identified in humans in 1995, and its protein product confirmed in mice that same year.